Abstract
Structures of membrane associated peptides and molecular interactions between peptides and cell membrane bilayers govern biological functions of these peptides. Sum frequency generation (SFG) vibrational spectroscopy has been demonstrated to be a powerful technique to study such structures and interactions at the molecular level. In this research, SFG has been applied, supplemented by attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR), to characterize interactions between alamethicin (a model for larger channel proteins) and different lipid bilayers in the absence of membrane potential. The orientation of alamethicin in lipid bilayers has been determined using SFG amide I spectra detected with different polarization combinations. It was found that alamethicin adopts a mixed α-helical and 310- helical structure in fluid-phase lipid bilayers. The helix (mainly α-helix) at the N-terminus tilts at about 63° versus the surface normal in a fluid-phase 1,2-Dimyristoyl-D54-sn-Glycero-3-Phosphocholine-1,1,2,2-D4-N,N,N-trimethyl-D9 (d-DMPC)/1,2-Dimyristoyl-sn-Glycero-3-Phosphocholine (DMPC) bilayer. The 310 helix at the C-terminus (beyond the Pro14 residue) tilts at about 43° versus the surface normal. This is the first time to apply SFG to study a 310 helix experimentally. When interacting with a gel-phase lipid bilayer, alamethicin lies down on the gel-phase bilayer surface and/or aggregates, which does not have significant insertion into the lipid bilayer.
1. Introduction
Ion channels represent an important class of transmembrane proteins that regulate the ionic permeability in cell membranes. They are key elements in signaling and sensing pathways, as well as connecting the inside of the cell to its outside in a selective fashion.1 They play crucial roles in normal and pathophysiological functions of cells. Defective ion channels can lead to many diseases such as cystic fibrosis, cardiac arrhythmias, and Parkinson’s disease.2–9 Investigations on structures of these membrane proteins will aid in the understanding of disease mechanisms and provide important clues to cure such diseases.
Alamethicin is a 20-residue hydrophobic antibiotic peptide extracted from the fungus Trichoderma viride that can form voltage-gated ion channels in membranes.10–23 It has been used frequently as a model for larger channel proteins.10–18 In addition to the regular amino acids, the peptide contains eight aminoisobutyric acid units. The molecular structure and conformational features of alamethicin have been studied extensively.10–27 The crystal structure of alamethicin crystallized from methanol determined by X-ray diffraction is predominantly helical, with an N-terminal α-helix and a C-terminal domain beyond Pro14 residue that contains 310-helical element.24 Pro14 residue acts as a bend in the helix and the bend angle between the two helical axes is about 20° to 35°.24
Extensive research has been performed to examine the mechanisms of alamethicin’s action on cell membranes.10–23 It is currently believed that alamethicin interacts with cell membranes through the barrel-stave mode with the resulting conducting pores in the membrane formed by parallel bundles of three to twelve helical alamethicin monomers surrounding a central, water-filled pore.12,13,22–24,28–30 However, further details on the mechanism of alamethicin channel formation at the molecular level are still far from completion.31,32 In addition, contradictory orientations of alamethicin in the cell membranes in the absence of membrane potential have been reported. Alamethicin has been suggested to adopt a transmembrane orientation,25–27, 33–37 lie down on the membrane surface,38–40 or both (depending on the experimental conditions).41,42 A continuous distribution of orientations has also been proposed.43
A detailed characterization of interactions between alamethicin and model membranes without a transmembrane potential is a fundamental step in the understanding of the operational mechanisms of ion channels. However, as mentioned above, different results have been reported in the literature. In this research, we applied sum frequency generation (SFG) vibrational spectroscopy, supplemented by attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR), to investigate the interactions between alamethicin and different lipid bilayers. SFG is a nonlinear optical laser technique which provides vibrational spectra of surfaces and interfaces.44–66 It has several advantages over other analytical techniques: it is intrinsically surface sensitive, requires small amount of samples, and can probe surfaces and interfaces in situ in real-time. As a polarized vibrational spectroscopy, SFG permits the identification of interfacial molecular species (or chemical groups), and also provides information about the interfacial structure, such as the orientation and the orientation distribution of functional groups on a surface or at an interface.44–55 SFG has been applied to study the structure and orientation of various biomolecules (including peptides and proteins) in interfacial environments.56–64 Here we deduced the orientation of alamethicin by analyzing the polarized SFG amide I signals without the presence of membrane potential, which will serve as a basis for future SFG studies on alamethicin under membrane potential. In addition, we also investigated the lipid chain length effect on the interactions of alamethicin with model membranes using SFG.
2. Experimental
2.1. Materials
Alamethicin from Trichoderma viride was purchased from Sigma-Aldrich (St. Louis, MO), with a minimum purity of 90%. Different lipids (listed in Table 1) were purchased from Avanti Polar Lipids (Alabaster, AL). Deuterated water (D2O) was ordered from Aldrich (Milwaukee, WI). Right-angle CaF2 prisms were purchased from Altos (Trabuco Canyon, CA).
Table 1.
Lipids studied in this paper
| Abbr. | Full Name |
|---|---|
| POPC | 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine |
| POPG | 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)] (Sodium Salt) |
| DMPC | 1,2-Dimyristoyl-sn-Glycero-3-Phosphocholine |
| d-DMPC | 1,2-Dimyristoyl-D54-sn-Glycero-3-Phosphocholine-1,1,2,2-D4-N,N,N-trimethyl-D9 |
| DPPC | 1,2-Dipalmitoyl-sn-Glycero-3-Phosphocholine |
| d-DPPC | 1,2-Dipalmitoyl-D62-sn-Glycero-3-Phosphocholine-1,1,2,2-D4-N,N,N-trimethyl-D9 |
| DPPG | 1,2-Dipalmitoyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)] (Sodium Salt) |
| d-DPPG | 1,2-Dipalmitoyl-D62-sn-Glycero-3-[Phospho-rac-(1-glycerol)] (Sodium Salt) |
| DSPC | 1,2-Distearoyl-sn-Glycero-3-Phosphocholine |
| d-DSPC | 1,2-Distearoyl-D70-sn-Glycero-3-Phosphocholine-1,1,2,2-D4-N,N,N-trimethyl-D9 |
All of the chemicals were used as received. CaF2 prisms were thoroughly cleaned using a procedure with several steps: They were first soaked in toluene for 24 h and then sonicated in Contrex AP solution from Decon Labs (King of Prussia, PA) for 1 h. After that, they were rinsed with deionized (DI) water before soaking in methanol for 10 minutes. All of the prisms were then rinsed thoroughly with an ample amount of DI water and cleaned inside a glow discharge plasma chamber for 4 min immediately before depositing lipid molecules on them. Substrates were tested using SFG, and no signal from contamination was detected.
2.1.1 Preparation of lipid bilayers
Single lipid bilayers which can have two different leaflets were prepared on CaF2 substrates. Langmuir-Blodgett and Langmuir-Schaefer (LB/LS) methods were used to deposit the proximal and then the distal leaflets, respectively. A KSV2000 LB system and ultrapure water from a Millipore system (Millipore, Bedford, MA) were used throughout the experiments for bilayer preparation. The detailed procedure was reported previously65,66 and will not be repeated here.
The bilayer was immersed in water inside a 1.6-mL reservoir throughout the entire experiment and a small amount of water could be added to the reservoir to compensate for evaporation when needed for long timescale experiments. For alamethicin-bilayer interaction experiments, ~15 μL alamethicin solution (in methanol with a concentration of 2.5 mg/mL) was injected into the reservoir. A magnetic micro stirrer was used to ensure a homogeneous concentration distribution of peptide molecules in the subphase below the bilayer.
2.2 Polarized ATR-FTIR Experiments
A Nicolet Magna-IR 550 spectrometer was used to collect attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectra with a standard 45° ZnSe ATR cell and a ZnSe grating polarizer (from Optometrics LLC). The ZnSe crystal (Specac Ltd. Woodstock, GA) was cleaned using the same procedures as the CaF2 prisms. The lipid bilayers were prepared onto the ZnSe crystal surface using the LB/LS method mentioned above. After the lipid bilayer was deposited onto the crystal, the water that kept the bilayer hydrated was flushed multiple times with D2O to avoid signal confusion between the O-H bending mode and the peptide amide I mode and to ensure a better S/N ratio in the peptide amide I band frequency region. After at least 2 h to allow equilibration, a background polarized spectrum of the lipid bilayer/D2O interface was recorded. Then about 15 μL alamethicin solution (in methanol with a concentration of 2.5 mg/mL) was injected into the above small reservoir of 1.6 mL. After at least 1 h to allow the alamethicin adsorption to reach equilibrium, a polarized spectrum was collected. Finally, the amide I signal of alamethicin on bilayer in D2O was obtained by subtracting the background spectrum of the bilayer/D2O interface from the later collected spectrum after alamethicin was adsorbed and equilibrated. All the spectra collected here were averages of 256 scans with a 2 cm−1 resolution.
2.3 SFG
SFG is a second-order nonlinear optical spectroscopic technique that has submonolayer surface sensitivity.44–66 Details regarding SFG theories and measurements have been extensively published44–66 and will not be repeated here. The SFG experimental setup was similar to that described in our earlier publications and will not be presented.65,66 In this research, all of the SFG experiments were carried out at the room temperature (25 °C). SFG spectra from interfacial alamethicin with different polarization combinations including ssp (s-polarized SF output, s-polarized visible input, and p-polarized infrared input) and ppp were collected using the near total internal reflection geometry.
2.4 Orientation Determination of Peptides
2.4.1 Orientation angle of peptides deduced from ATR-FTIR
ATR-FTIR spectroscopy has been widely used to analyze peptide/protein secondary structures on surfaces or at interfaces and determine the orientation of such secondary structures.67 In ATR-FTIR studies, the tilt angle (θ) of the helices can be determined from the measured infrared linear dichroic ratio (R) in ATR-FTIR using p- and s-polarized IR beams:67,68
| (1) |
where Ei (i=x,y,z) is the electric field amplitude of the evanescent wave at the surface of the internal reflection element, and ki (i=x,y,z) is a component of the integrated absorption coefficient in the lab fixed coordinate system. Ei (i=x,y,z) depends on the incidence angle of the IR beam at the solid-liquid interface, and the refractive indices of the internal reflection element (ATR crystal), the thin film (bilayer), and the bulk contacting medium (D2O). We calculated the value of Ei (i=x,y,z) using the formula published in the literature.67,68 If we model the orientation distribution of a helix in the lab-fixed coordinate system as a Gaussian distribution ( ), ki (i=x,y,z) is given as follows:68
| (2) |
| (3) |
where θ and σ are the tilt angle between the helix’s principal axis and the surface normal and the orientation distribution width respectively; α is the angle between the transition dipole moment and the principal axis of the helix, which equals to 38° for α-helix and 45° for 310 helix.69,70 The bracket denotes the time and ensemble average. When σ = 0, the orientation distribution is a δ-distribution. Since ATR-FTIR only provides one experimentally measured parameter (R), based on the eqns (1) to (3), the tilt angle θ can be determined by knowing the value of Ei (i=x,y,z), and α, and assuming a certain value of σ. Here we used a delta distribution.
2.4.2 Orientation angle of peptides deduced from SFG
The molecular orientation information can be obtained by relating SFG susceptibility tensor elements χijk(i, j,k = x, y, z) to the SFG molecular hyperpolarizability tensor elements βlmn (l,m,n = a,b,c).44–66 Our lab has developed a methodology to determine the orientation of α-helical structure using SFG amide I spectra collected with different polarization combinations. This method has been introduced in our previous papers 66, 71–75 and will not be repeated here.
Similar to the method for an α-helix, we developed the orientation analysis method for a 310-helix in membrane.72 We deduced the relation between the χppp/χssp value and the 310-helix orientation with a δ- or Gaussian distribution using different hyperpolarizability tensor elements with the adoption of the bond additivity model. Thus the orientation angle (θ) of 310 helix can be deduced by measuring the ppp and ssp spectral intensity ratio of the peptide amide I signals.
3. Results and Discussion
3.1 Interaction between Alamethicin and d-DMPC/DMPC Bilayer
3.1.1 SFG results
SFG ssp and ppp spectra of alamethicin in a d-DMPC/DMPC bilayer are shown in Fig. 1. The spectra were collected after 15 μL alamethicin/methanol solution was injected into the subphase (~1.6 mL) of a d-DMPC/DMPC bilayer at pH 6.7. The SFG spectra are dominated by two peaks at 1635 cm−1 and 1670 cm−1, which is consistent with the results of previous FTIR and Raman studies in which the amide I peaks centered at 1639 and 1662 cm−1 were observed in membrane-incorporated alamethicin.76–78 The frequency of the 1662 cm−1 peak in IR spectra is higher than those normally found for soluble or membrane-inserted α-helices (usually at about 1650 cm−1). Chapman et al. conclude that this higher frequency is an indication for a 310-helical structure connected to the α-helix in alamethicin in lipid bilayers.76 Therefore we believe that the 1670 cm−1 peak observed in the SFG spectra is contributed by a helical structure dominated by α-helix but with a 310-helix part. Peak assignments in the literature indicate that the 1635 cm−1 peak is due to the 310-helix.76–79
Figure 1.
SFG spectra of alamethicin in a d-DMPC/DMPC bilayer at pH=6.7. Top: ssp spectrum; bottom: ppp spectrum.
Alamethicin is consisted of two helical segments because of the presence of the helix-breaking Pro14 residue.24 According to the above discussion, the 310-helix formed by residues 14 to 20 contributes to the signal at 1635 cm−1; the α-helical/310-helical structure (mainly α-helical component) which contains residues 1 to 13 contributes to the signal at 1670 cm−1. Here, we define the tilt angle between the principal axis of the helix with the residues 1 to 13 and the d-DMPC/DMPC bilayer surface normal to be θ1, while the tilt angle between the principal axis of the helix composed of residues 14 to 20 and the d-DMPC/DMPC bilayer surface normal to be θ2.
A) Orientation of 310 helix containing residues 14–20 (θ2)
Using the relation between the measured ppp and ssp spectral intensity ratio of the peak at 1635 cm−1, we should be able to determine the orientation angle (θ2). We deduced the hyperpolarizability tensor elements for a 310 helix that consists of 7 amino acid residues and obtained βaca =0.54βccc and βaac= 1.1βccc. Details regarding the deduction of specific tensor elements of 310 helix were reported previously72 and will not be repeated here. As a result of the deduction, a relation between the measured χppp/χssp ratio and the 310 helix orientation for a 310 helix with 7 amino acids is presented in Fig. 2.72 Here the experimental measured χppp/χssp ratio of the peak at 1635 cm−1 in the d-DMPC/DMPC bilayer is 1.80±0.15, therefore the orientation angle θ2 is about 43° (between 39° and 47°). The number of amino acid residues in an ideal 310 helix should be multiples of 3. There are some concerns that the 310-helical symmetry may be slightly broken when the number of the amino acids in a 310 helix deviates from multiples of 3. In that case, the relation between the χppp/χssp value and 310 helix orientation may vary when the number of the amino acids in a 310 helix changes. To address the above concern, we calculated βaac/βccc, βaca/βccc for 310 helices having 3 to 7 amino acids.72 Using the calculated parameters, the ratio of χppp/χssp as a function of 310-helix orientation angle (θ2) can be deduced. The results indicated that the orientation determination is not noticeably affected by the numbers of amino acids in a 310-helix when the tilt angle is smaller than 50°.
Figure 2.
The relation between SFG susceptibility tensor component ratio and the 310-helix orientation angle. The measured orientation angle is about 43° (between 39° and 47°) assuming a narrow angle distribution.
B) Orientation of the helix containing residues 1 to 13 (θ1)
The orientation angle (θ1) can be deduced by using the relation between the measured ppp and ssp spectral intensity ratio of the peak at 1670 cm−1. We deduced the hyperpolarizability tensor elements for the helix that consists of residues 1 to 13, which contains both α- and 310- helical structures (mainly α-helical elements). Recently, Salnikov et al. studied the structure and alignment of uniformly 15N-labeled alamethicin in POPC and DMPC membranes using oriented 15N and 31P solid state NMR spectroscopy.27 A model structure with α-helix formed by the first ten residues and 310-helix formed by the next ten residues was found to be able to predict the features in the observed NMR spectrum reasonably well.27 Here we propose that the helix formed by residues 1 to 13 has two portions, an α-helix formed by the first ten residues and a 310-helix formed by the residues 11 to 13. The relation between the χppp/χssp ratio of this structure and its membrane orientation is presented in Fig. 3. The experimentally measured χppp/χssp ratio for the peak at 1670 cm−1 in the d-DMPC/DMPC bilayer is about 2.45±0.15, yielding an orientation angle θ1 of about 63° (between 57° and 68°). Although this value of θ1 is deduced from the above proposed structure with α-helix formed by the first ten residues and 310 helix formed by residues 11 to 13, θ1 does not substantially change when different structures were used in orientation determination, as shown in Table 2.
Figure 3.
The relation between SFG susceptibility tensor component ratio for the helix containing 1–13 residues and the helix orientation angle. The measured orientation angle is about 63° (between 57° and 68°) assuming a narrow angle distribution.
Table 2.
The orientation angle θ1 of different proposed structures of the helix containing residues 1 to 13 in alamethicin
| Modeling structure | Structure description | Orientation angle(θ1) |
|---|---|---|
| Model 1 | α-helix with 1–10 residues, 310-helix with 11–13 residues | 63(between 57 and 68°) |
| Model 2 | α-helix with 1-9 residues, 310-helix with 10–13 residues | 64(between 58 and 70°) |
| Model 3 | α-helix with 1–11 residues, 310-helix with 12–13 residues | 64(between 57 and 69°) |
| Model 4 | Only α-helix with 1–10 residues | 63(between 56 and 69°) |
We note that the bend angle between the two helical components in alamethicin (θ1–θ2) is about 20° in this study, assuming the plane containing both helical components are perpendicular to the membrane surface. This is in excellent agreement with previous results: 17° was reported in DMPC-bilayer associated alamethicin,26 and 20–35° in crystallized alamethicin.24
3.1.2 ATR-FTIR results
ATR-FTIR was used as a supplemental technique to substantiate SFG results. ATR-FTIR polarized spectra of alamethicin in a d-DMPC/DMPC bilayer are displayed in Fig. 4. According to the previous results in the literature, we fit these spectra using three peaks centered at 1623, 1635 and 1660 cm−1. The intensity ratio (R) of the signal measured using the p- versus s- polarized beam is 1.7 for the 1635 cm−1 peak and 1.6 for the 1660 cm−1 peak. From this R value, the orientation angle can be calculated to be 55° for θ1 (between 52° and 58°) and 49° for θ2 (between 45° and 53°), assuming a δ-orientation distribution; they are not very different from the SFG results of θ1 =63° and θ2 = 43° presented above. The difference between the SFG and ATR-FTIR results might be due to the fact that the orientation distribution is not a delta-distribution.
Figure 4.
Polarized ATR-FTIR spectra of alamethicin in a d-DMPC/DMPC bilayer at pH=6.7. Top: p-polarized spectrum; bottom: s-polarized spectrum.
Our SFG and ATR-FTIR studies both indicated that alamethicin molecules exhibit a large tilt angle versus the surface normal in a d-DMPC/DMPC bilayer. These results agree with those from recent ATR-FTIR research on fluid-phase lipid membrane associated alamethicin.32,36 Marsh reported that the tilt angle of alamethicin is 67° in 1,2-didecanoyl-sn-glycero-3-phosphocholine membranes, and 51° in 1,2-diundecanoyl-sn-glycero-3-phosphocholine membranes at 36 °C.36 In addition, Stella et al. observed that the tilt angle of alamethicin is about 60° in a POPC bilayer membrane.32
In contrast, our results are quite different from those obtained from labeled alamethicin in NMR or electron paramagnetic resonance (EPR) studies. Site-specific 15N-labeled alamethicin was found to be more or less parallel to the DMPC bilayer normal,25 or slightly tilted (10° to 20°) determined by solid-state 15N NMR.26 In addition, it was shown by solid-state 15N and 31P NMR spectroscopy that uniformly 15N-labeled alamethicin orients parallel to the POPC and DMPC membrane surface normal.27 EPR studies indicated that TOAC-substituted alamethicin orients with a tilt angle varying from 23° to 13° in fluid-phase diacyl phosphatidylcholine bilayer at 75 °C.35 It has been suggested that the measured orientation of alamethicin on membranes depends on the experimental conditions.41,42 We also agree that the different methods may lead to varying results. NMR studies require complicated sample preparation procedures as well as exogenous labels. The effective order parameters measured by EPR with TOAC-substituted alamethicin are relative to the local membrane director.35 This local tilt of transmembrane polypeptides has been augmented by thermally excited elastic bending fluctuations of the entire membrane.80,81 These fluctuations can change the elastic modulus for membrane area expansion,82 facilitating the insertion of transmembrane proteins/peptides, and also give rise to a net inclination of the local membrane normal (or director), to which the molecular tilt of the peptide is referred.82
3.2 Interaction between Alamethicin and Different Lipid Bilayers
It has been shown that the membrane lipid chain length affects the interactions between alamethicin and cell membranes.21,34–36,83,84 Recently, Marsh et al. investigated the dependence of the incorporation of spin-labeled alamethicin into fluid phosphatidylcholine membrane bilayers on lipid chain length using EPR. Their results suggested the orientation and aggregation of alamethicin are related to the chain length of the lipid. Lipid chain length can modulate the activity of transmembrane proteins/peptides by the mismatch between the hydrophobic span of the protein/peptide and the lipid membrane.34–36 In this study, we observed markedly different SFG signal intensities from alamethicin in bilayers with lipids of different chain lengths. The different lipids examined and varied SFG results are listed in Table 3. It is well known that the lipid chain length is one of the factors that determine the phase of the lipid bilayer at the room temperature: Similar lipids with longer chains tend to exist in the gel phase, whereas with shorter chains are likely in the fluid phase.
Table 3.
Interactions between alamethicin and different lipid bilayers.
| Inner layer | Outer layer | Transition temperature of Phase of outer layer lipid | SFG signal | |
|---|---|---|---|---|
| outer layer lipid (°C)* | at experimental condition | |||
| POPC | POPC | −2 | Fluid | Very strong |
| POPC | POPG | −2 | Fluid | Very strong |
| d-DMPC | d-DMPC | 23 | Fluid | Very strong |
| d-DMPC | DMPC | 23 | Fluid | Very strong |
| d-DPPC | DPPC | 41 | Gel | Weak |
| d-DPPG | DPPG | 41 | Gel | Weak |
| d-DSPC | DSPC | 55 | Gel | Weak |
Fig. 5 shows the ppp SFG spectra collected after 15 μL alamethicin/methanol solution was injected into the subphase (~ 1.6 mL) of various bilayers. In the fluid-phase lipid bilayers (Fig. 5a–d), strong SFG amide I signals of alamethicin were observed, dominated by two peaks at 1635 and 1670 cm−1. These two peaks are contributed by the 310-helical structure and the α-helical structure of alamethicin. Using the orientation analysis method discussed above, the orientations of alamethicin in different lipids were investigated. The deduced results indicated that the orientations of alamethicin in different fluid-phase lipid bilayers (POPC/POPC, POPC/POPG, DMPC/DMPC bilayers) are similar to each other, and thus also similar to the one presented above regarding the d-DMPC/DMPC bilayer. Therefore it is concluded that alamethicin has a highly ordered orientation in fluid-phase lipid bilayers with a large tilt angle.
Figure 5.
SFG ppp spectra of alamethicin in different bilayers at pH=6.7. a) POPC/POPC; b) POPC/POPG; c) d-DMPC/DMPC; d) d-DMPC/d-DMPC; e) d-DPPC/DPPC; f) d-DPPG/DPPG; g) d-DSPC/DSPC.
When alamethicin was interacting with gel-phase lipid bilayers (Fig. 5e–g), only two weak SFG peaks at 1685 and 1720 cm−1 were observed. We believe that the peak at 1685 cm−1 is contributed by the antiparallel β-sheet or aggregated strand of peptides.61,67 The 1720 cm−1 signal is not the amide I signal from alamethicin; instead it originates from the carbonyl groups of the lipid bilayer. The absence of the strong alamethicin helical signal on gel-phase lipid bilayer indicates that both the helical structures lie down on the lipid bilayer surface and/or may be changed into other secondary structures, e.g., antiparallel β-sheet or aggregated strand. This is consistent with the results obtained using other analytical tools in the literature.38–40 Therefore, it is evident that alamethicin interacts with gel-phase and fluid-phase lipid bilayers differently.
4. Conclusion
We applied SFG to investigate the molecular interactions between alamethicin, an important model for larger channel proteins, and different lipid bilayers in situ and in real time without exogenous labeling. It was found that alamethicin interacts differently with gel-phase versus fluid-phase lipid bilayers. When alamethicin molecules interact with gel-phase lipid bilayers, they lie down and/or aggregate on the gel-phase bilayer surface. We believe that they do not have significant insertion into the lipid bilayers. Differently, alamethicin molecules can insert into fluid-phase lipid bilayers with large tilt angels in the absence of membrane potential. The orientation of alamethicin in fluid-phase lipid bilayers was determined by deducing the orientations of the α- and 310- helical structural segments using polarized SFG amide I spectra, and substantiated by the polarized ATR-FTIR studies. According to our knowledge, this is the first time to successfully apply SFG to determine orientation of a 310- helix experimentally. The formation of channels by alamethicin under membrane potential will be investigated in the future to elucidate molecular mechanisms of these channels.
Acknowledgments
This research is supported by National Institute of Health (1R01GM081655-01A2) and Office of Naval Research (N00014-02-1-0832 and N00014-08-1-1211). SY acknowledges the start-up funding from University of Science and Technology of China and Chinese Universities Scientific Fund.
References
- 1.Kelkar DA, Chattopadhyay A. Biochim Biophys Acta. 2007;1768:2011–2025. doi: 10.1016/j.bbamem.2007.05.011. [DOI] [PubMed] [Google Scholar]
- 2.Cooper EC, Jan LY. Proc Natl Acad Sci USA. 1999;96:4759–4766. doi: 10.1073/pnas.96.9.4759. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Jentsch TJ, Hübner CA, Fuhrmann JC. Nat Cell Biol. 2004;6:1039–1047. doi: 10.1038/ncb1104-1039. [DOI] [PubMed] [Google Scholar]
- 4.Verkman AS, Galietta LJV. Nat Rev Drug Discov. 2009;8:153–171. doi: 10.1038/nrd2780. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Berger AL, Ikuma M, Welsh MJ. Proc Natl Acad Sci USA. 2005;102:455–460. doi: 10.1073/pnas.0408575102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Gadsby DC, Vergani P, Csanady L. Nature. 2006;440:477–483. doi: 10.1038/nature04712. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Tan HL, Bink-Boelkens MTE, Bezzina CR, Viswanathan PC, Beaufort-Krol GCM, van Tintelen PJ, van den Berg MP, Wilde AAM, Balser JR. Nature. 2001;409:1043–1047. doi: 10.1038/35059090. [DOI] [PubMed] [Google Scholar]
- 8.Armstrong N, Sun Y, Chen GQ, Gouaux E. Nature. 1998;395:913–917. doi: 10.1038/27692. [DOI] [PubMed] [Google Scholar]
- 9.Stutts MJ, Canessa CM, Olsen JC, Hamrick M, Cohn JA, Rossier BC, Boucher RC. Science. 1995;269:847–850. doi: 10.1126/science.7543698. [DOI] [PubMed] [Google Scholar]
- 10.Sansom MSP. Prog Biophys Mol Biol. 1991;55:139–235. doi: 10.1016/0079-6107(91)90004-c. [DOI] [PubMed] [Google Scholar]
- 11.Woolley GA, Wallace BA. J Mem Biol. 1992;129:109–136. doi: 10.1007/BF00219508. [DOI] [PubMed] [Google Scholar]
- 12.Sansom MSP. Eur Biophys J. 1993;22:105–124. doi: 10.1007/BF00196915. [DOI] [PubMed] [Google Scholar]
- 13.Sansom MSP. Quart Rev Biophys. 1993;26:365–421. doi: 10.1017/s0033583500002833. [DOI] [PubMed] [Google Scholar]
- 14.Cafiso DS. Annu Rev Biophys Biomol Struct. 1994;23:141–165. doi: 10.1146/annurev.bb.23.060194.001041. [DOI] [PubMed] [Google Scholar]
- 15.Marsh D. Biochem J. 1994;23:345–361. doi: 10.1042/bj3150345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Bechinger B. J Mem Biol. 1997;156:197–211. doi: 10.1007/s002329900201. [DOI] [PubMed] [Google Scholar]
- 17.Duclohier H, Wroblewski H. J Mem Biol. 2001;184:1–12. doi: 10.1007/s00232-001-0077-2. [DOI] [PubMed] [Google Scholar]
- 18.Nagaraj R, Balaram P. Acc Chem Res. 1981;14:356–362. [Google Scholar]
- 19.Kessel A, Cafiso DS, Ben-Tal N. Biophys J. 2000;78:571–583. doi: 10.1016/S0006-3495(00)76617-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Mathew MK, Balaram P. Mol Cell Biochem. 1983;50:47–64. doi: 10.1007/BF00225279. [DOI] [PubMed] [Google Scholar]
- 21.Hall JE, Vodyanoy I, Balasubramanian TM, Marshall GR. Biophys J. 1984;45:233–247. doi: 10.1016/S0006-3495(84)84151-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Mathew MK, Balaram P. FEBS Lett. 1983;157:1–5. doi: 10.1016/0014-5793(80)80733-2. [DOI] [PubMed] [Google Scholar]
- 23.Leitgeb B, Szekeres A, Manczinger L, Vagvolgyi C, Kredics L. Chem BioDivers. 2007;4:1027–1051. doi: 10.1002/cbdv.200790095. [DOI] [PubMed] [Google Scholar]
- 24.Fox RO, Richards FM. Nature. 1982;300:325–330. doi: 10.1038/300325a0. [DOI] [PubMed] [Google Scholar]
- 25.North CL, Barranger-Mathys M, Cafiso DS. Biophys J. 1995;69:2392–2397. doi: 10.1016/S0006-3495(95)80108-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Bak M, Baywater RP, Hohwy M, Thomsen JK, Adelhorst K, Jakobsen HJ, Sorensen OW, Nielsen NC. Biophys J. 2001;81:1684–1698. doi: 10.1016/S0006-3495(01)75822-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Salnikov ES, Friedrich H, Li X, Bertani P, Reissmann S, Hertweck C, O’Neil JDJ, Raap J, Bechinger B. Biophys J. 2009;96:86–100. doi: 10.1529/biophysj.108.136242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Duclohier H. Eur Biophys J. 2004;33:169–174. doi: 10.1007/s00249-003-0383-y. [DOI] [PubMed] [Google Scholar]
- 29.Laver DR. Biophys J. 1994;66:355–359. doi: 10.1016/s0006-3495(94)80784-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Vodyanoy I, Hall JE, Balasubramanian TM. Biophys J. 1983;42:71–82. doi: 10.1016/S0006-3495(83)84370-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Milov AD, Samoilova RI, Tsvetkov YD, Zotti MD, Toniolo C, Raap J. J Phys Chem B. 2008;112:13469–13472. doi: 10.1021/jp8046714. [DOI] [PubMed] [Google Scholar]
- 32.Stella L, Burattini M, Mazzuca C, Palleschi A, Venanzi M, Coin I, Peggion C, Toniolo C, Pispisa B. Chem Biodivers. 2007;4:1299–1312. doi: 10.1002/cbdv.200790111. [DOI] [PubMed] [Google Scholar]
- 33.Kessel A, Cafiso DS, Ben-Tal N. Biophys J. 2000;78:571–583. doi: 10.1016/S0006-3495(00)76617-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Marsh D, Jost M, Peggion C, Toniolo C. Biophys J. 2007;92:473–481. doi: 10.1529/biophysj.106.092775. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Marsh D, Jost M, Peggion C, Toniolo C. Biophys J. 2007;92:4002–4011. doi: 10.1529/biophysj.107.104026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Marsh D. Biochemistry. 2009;48:729–737. doi: 10.1021/bi801279n. [DOI] [PubMed] [Google Scholar]
- 37.Salnikov ES, Zotti MD, Formaggio F, Li X, Toniolo C, O’Neil JDJ, Raap J, Dzuba SA, Bechinger B. J Phys Chem B. 2009;113:3034–3042. doi: 10.1021/jp8101805. [DOI] [PubMed] [Google Scholar]
- 38.Banerjee U, Zidovetzki R, Birge RR, Chan SI. Biochemistry. 1985;24:7621–7627. doi: 10.1021/bi00347a019. [DOI] [PubMed] [Google Scholar]
- 39.Ionov R, El-Abed A, Angelova A, Goldmann M, Peretti P. Biophys J. 2000;78:3026–3035. doi: 10.1016/S0006-3495(00)76841-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Mottamal M, Lazaridis T. Biophys Chem. 2006;122:50–57. doi: 10.1016/j.bpc.2006.02.005. [DOI] [PubMed] [Google Scholar]
- 41.Chen FY, Lee MT, Huang HW. Biophys J. 2002;82:908–914. doi: 10.1016/S0006-3495(02)75452-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Huang HW, Wu Y. Biophys J. 1991;60:1079–1087. doi: 10.1016/S0006-3495(91)82144-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Spaar A, Munster C, Salditt T. Biophys J. 2004;87:396–407. doi: 10.1529/biophysj.104.040667. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Miranda PB, Shen YR. J Phys Chem B. 1999;103:3292–3307. [Google Scholar]
- 45.Kim J, Somorjai GA. J Am Chem Soc. 2003;125:3150–3158. doi: 10.1021/ja028987n. [DOI] [PubMed] [Google Scholar]
- 46.Kim J, Cremer PS. ChemPhysChem. 2001;2:543–546. doi: 10.1002/1439-7641(20010917)2:8/9<543::AID-CPHC543>3.0.CO;2-5. [DOI] [PubMed] [Google Scholar]
- 47.Li G, Ye S, Morita S, Nishida T, Osawa M. J Am Chem Soc. 2004;126:12198–12199. doi: 10.1021/ja046183x. [DOI] [PubMed] [Google Scholar]
- 48.Voges AB, Al-Abadleh HA, Musorrariti MJ, Bertin PA, Nguyen ST, Geiger FM. J Phys Chem B. 2004;108:18675–18682. [Google Scholar]
- 49.Li QF, Hua R, Chea IJ, Chou KC. J Phys Chem B. 2008;112:694–697. doi: 10.1021/jp072147j. [DOI] [PubMed] [Google Scholar]
- 50.Ye HK, Gu ZY, Gracias DH. Langmuir. 2006;22:1863–1868. doi: 10.1021/la052030r. [DOI] [PubMed] [Google Scholar]
- 51.Yatawara AK, Tiruchinapally G, Bordenyuk AN, Andreana PR, Benderskii AV. Langmuir. 2009;25:1901–1904. doi: 10.1021/la803113h. [DOI] [PubMed] [Google Scholar]
- 52.Perry A, Ahlborn H, Space B, Moore PB. J Chem Phys. 2003;118:8411–8419. [Google Scholar]
- 53.Liu J, Conboy JC. Biophys J. 2005;89:2522–2532. doi: 10.1529/biophysj.105.065672. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Chen X, Wang J, Sniadecki JJ, Even MA, Chen Z. Langmuir. 2005;21:2662–2664. doi: 10.1021/la050048w. [DOI] [PubMed] [Google Scholar]
- 55.Ye SJ, McClelland A, Majumdar P, Stafslien S, Daniels J, Chisholm B, Chen Z. Langmuir. 2008;24:9686–9694. doi: 10.1021/la800769z. [DOI] [PubMed] [Google Scholar]
- 56.Wang J, Paszti Z, Clarke ML, Chen X, Chen Z. J Phys Chem B. 2007;111:6088–6095. doi: 10.1021/jp070383o. [DOI] [PubMed] [Google Scholar]
- 57.Chen X, Wang J, Paszti Z, Wang F, Schrauben JN, Tarabara VV, Schmaier AH, Chen Z. Anal Bioanal Chem. 2007;388:65–72. doi: 10.1007/s00216-006-0999-8. [DOI] [PubMed] [Google Scholar]
- 58.Wang J, Chen X, Clarke ML, Chen Z. J Phys Chem B. 2006;110:5017–5024. doi: 10.1021/jp0534683. [DOI] [PubMed] [Google Scholar]
- 59.Clarke ML, Wang J, Chen Z. J Phys Chem B. 2005;109:22027–22035. doi: 10.1021/jp054456k. [DOI] [PubMed] [Google Scholar]
- 60.Wang J, Clarke ML, Chen X, Even MA, Johnson WC, Chen Z. Surf Sci. 2005;587:1–11. [Google Scholar]
- 61.Ye SJ, Nguyen KT, Le Clair S, Chen Z. J Struct Biol. 2009;168:61–77. doi: 10.1016/j.jsb.2009.03.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Chen X, Chen Z. Biochim Biophys Acta. 2006;1758:1257–1273. doi: 10.1016/j.bbamem.2006.01.017. [DOI] [PubMed] [Google Scholar]
- 63.Chen X, Clarke ML, Wang J, Chen Z. Int J Mod Phys B. 2005;19:691–713. [Google Scholar]
- 64.Ye SJ, Nguyen KT, Boughton AP, Mello CM, Chen Z. Langmuir. 2010 doi: 10.1021/la903932w. in press ( http://pubs.acs.org/doi/pdf/10.1021/la903932w) [DOI] [PMC free article] [PubMed]
- 65.Chen X, Wang J, Kristalyn CB, Chen Z. Biophys J. 2007;93:866–875. doi: 10.1529/biophysj.106.099739. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Chen X, Wang J, Boughton AP, Kristalyn CB, Chen Z. J Am Chem Soc. 2007;129:1420–1427. doi: 10.1021/ja067446l. [DOI] [PubMed] [Google Scholar]
- 67.Tamm LK, Tatulian UA. Quart Rev Biophys. 1997;30:365–429. doi: 10.1017/s0033583597003375. [DOI] [PubMed] [Google Scholar]
- 68.Kass I, Arbey E, Arkin IT. Biophys J. 2004;86:2502–2507. doi: 10.1016/S0006-3495(04)74305-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Marsh D, Muller M, Schmitt F-J. Biophys J. 2000;78:2499–2510. doi: 10.1016/S0006-3495(00)76795-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Malcolm BR, Walkinshaw MD. Biopolymers. 1986;25:607–625. [Google Scholar]
- 71.Wang J, Lee SH, Chen Z. J Phys Chem B. 2008;112:2281–2290. doi: 10.1021/jp077556u. [DOI] [PubMed] [Google Scholar]
- 72.Nguyen KT, Le Clair S, Ye SJ, Chen Z. J Phys Chem B. 2009;113:12169–12180. doi: 10.1021/jp904153z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Nguyen KT, Le Clair S, Ye SJ, Chen Z. J Phys Chem B. 2009;113:12358–12363. doi: 10.1021/jp904154w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Lee S, Wang J, Krimm S, Chen Z. J Phys Chem A. 2006;110:7035–7044. doi: 10.1021/jp057200n. [DOI] [PubMed] [Google Scholar]
- 75.Chen X, Boughton AP, Tesmer JJG, Chen Z. J Am Chem Soc. 2007;129:12658–12659. doi: 10.1021/ja075542w. [DOI] [PubMed] [Google Scholar]
- 76.Haris PI, Chapman D. Biochim Biophys Acta. 1988;943:375–380. doi: 10.1016/0005-2736(88)90571-8. [DOI] [PubMed] [Google Scholar]
- 77.Haris PI, Molle G, Duclohier H. Biophys J. 2004;86:248–253. doi: 10.1016/S0006-3495(04)74100-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Vogel H. Biochemistry. 1987;26:4562–4572. doi: 10.1021/bi00388a060. [DOI] [PubMed] [Google Scholar]
- 79.Kennedy DF, Crisma M, Toniolo C, Chapman D. Biochemistry. 1991;30:6541–6548. doi: 10.1021/bi00240a026. [DOI] [PubMed] [Google Scholar]
- 80.Marsh D. Biophys J. 2008;94:3996–4013. doi: 10.1529/biophysj.107.121475. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Marsh D, Shanmugavadivu B, Kleinschmidt JH. Biophys J. 2006;91:227–232. doi: 10.1529/biophysj.105.079004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Marsh D. Biophys J. 1997;73:865–869. doi: 10.1016/S0006-3495(97)78119-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Archer SJ, Ellena JF, Cafiso DS. Biophys J. 1991;60:389–398. doi: 10.1016/S0006-3495(91)82064-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Barranger-Mathys M, Cafiso DS. Biophys J. 1994;67:172–176. doi: 10.1016/S0006-3495(94)80466-7. [DOI] [PMC free article] [PubMed] [Google Scholar]





